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Indications for resection of branch duct intraductal papillary mucinous neoplasms (IPMNs) remain controversial
because of their low tendency to be malignant. Surgical resection should be recommended if any factors indicating
malignancy are present. However, preoperative differentiation between benign and malignant tumors is very difficult,
especially in cases of branch duct IPMNs. We herein report a case of branch duct intraductal papillary mucinous adenoma
(IPMA) of the pancreas with a large mural nodule of 25 mm. A 74-year-old woman was admitted for examination and
treatment for a cystic tumor in the head of the pancreas. Magnetic resonance cholangiopancreatography and
computed tomography showed a cystic lesion, 50 mm in diameter, with an irregular mural nodule in the pancreatic
head. Endoscopic ultrasonography demonstrated a multicystic tumor connected with the main pancreatic duct (MPD).
The mural nodule had a diameter of 18 mm, and the MPD had a slight dilation of 6 mm. These findings suggested a
high potential for malignancy. The patient underwent pancreaticoduodenectomy with lymph node dissection. The
excised pancreas showed multiple cysts located in the branch pancreatic duct with a maximum diameter of 75 mm.
The mural nodule had a maximum diameter of 25 mm. The tumor was diagnosed as an IPMA by pathological
examination. After operation, the patient was discharged without any complications. Two years after resection,
the patient remains in remission with no evidence of tumor recurrence.
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Detection of intraductal papillary mucinous neoplasms
(IPMNs) of the pancreas has been increasing due to
recent advances in imaging. IPMNs can be malignant
and undergo transformation from an adenoma to inva-
sive carcinoma. International consensus guidelines from
2006 [1] and recently updated in 2012 [2] recommend
surgical resection of main duct IPMNs due to a high risk
of malignancy, ranging from 60% to 100%. On the other
hand, branch duct IPMNs have lower rate of malignancy
(6% to 51%) [3-5], although surgical resection should be
recommended if any factors indicating malignancy are
present. Large mural nodules are associated with a
higher risk of malignancy. However, differentiating be-
tween intraductal papillary mucinous adenoma (IPMA)
and intraductal papillary mucinous carcinoma (IPMC) is* Correspondence: haruki@jikei.ac.jp
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in any medium, provided the original work is poften difficult, especially in branch duct IPMNs. We
herein report a case of branch duct IPMA of the pan-
creas with a large mural nodule. To the best of our
knowledge, this case involves the largest mural nodule
diagnosed as branch duct IPMA reported so far in the
English literature.Case presentation
A 74-year-old woman presenting with epigastralgia was
admitted to our hospital for examination and treatment
for a cystic tumor in the pancreatic head. Laboratory
data showed slightly increased levels of P-type serum
amylase (57 U/l) and elastase-I (680 ng/dl). We also
measured the tumor markers carcinoembryonic antigen
(CEA, 3.7 ng/ml), carbohydrate antigen 19–9 (14 U/ml),
and DUPAN-2 (25 U/ml). Magnetic resonance cholan-
giopancreatography (MRCP) revealed a cystic lesion lo-
cated in the pancreatic head (Figure 1A,B) with a mural
nodule (Figure 1C), seen as a slight increase in intensityn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Magnetic resonance cholangiopancreatography. Magnetic resonance cholangiopancreatography revealed a cystic lesion located
in the pancreatic head (A, B) (arrow) with a mural nodule (C) (arrow head), seen as a slight increase in intensity on diffusion-weighted images
(D) (arrow head).
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tomography (CT) showed a cystic lesion, 50 mm in
diameter (Figure 2A), with an irregular mural nodule,
which showed gradual enhancement on enhanced CT
(Figure 2B). Endoscopic ultrasonography (EUS) demon-
strated a multicystic tumor connected with the main
pancreatic duct (MPD). The mural nodule had papillary
growth with a diameter of 18 mm (Figure 3A), and the
MPD was slightly dilated to 6 mm (Figure 3B). These
findings suggested malignant potential. The patient was
diagnosed with branch duct IPMC of the pancreas and
underwent pancreaticoduodenectomy with lymph node
dissection. The excised pancreas showed multiple cysts
located in the branch pancreatic duct with total dimen-
sions of 75 × 45 × 33 mm in the head of the pancreas. The
mural nodule was 25 × 20 × 18 mm in size (Figure 4A).
Pathological examination revealed a composition of papil-
lary structures consisting of pancreatobiliary-type mucin-Figure 2 Enhanced computed tomography. Computed tomography sho
irregular mural nodule, which showed gradual enhancement on enhancedcontaining columnar epithelial cells with low-grade atypia
(Figure 4B,C,D). These tumor cells were negative for p53
on immunohistochemistry. The tumor was diagnosed as
an IPMA. The patient was discharged 14 days post-
operation without any complications. Two years after re-
section, the patient remains in remission with no evidence
of tumor recurrence.
Discussion
IPMNs are an increasingly recognized entity represent-
ing a spectrum of benign and malignant neoplasms of
the pancreas. While there is a general consensus that all
main duct IPMNs should be resected, the indications for
resection of branch duct IPMNs remain controversial
because of their lower tendency for malignancy. The
guidelines include a flowchart covering the suggested
surgical resection and follow-up procedures for branch
duct IPMNs. Recent guidelines [2] recommended thatwed a cystic lesion with a diameter of 50 mm (A) (arrow) and an
CT (B) (arrow head).
Figure 3 Endoscopic ultrasonography. Endoscopic ultrasonography demonstrated a multicystic tumor connected with the main pancreatic duct
(MPD). The mural nodule had papillary growth with a diameter of 18 mm (A) (arrow), and the MPD had a slight dilation of 6 mm (B) (arrow head).
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testing if a patient with a cystic lesion of the pancreas
has obstructive jaundice, an enhancing solid component
within the cyst, or dilation of the MPD to ≥10 mm. Ac-
cording to the most recent guidelines, surgical resection
was therefore required in this case due to the presence
of an enhanced mural nodule. Moreover, older guide-
lines [1] recommended that resection should be per-
formed if any of the following five factors are present: a
cyst >3 cm in diameter, mural nodules, MPD dilation
to >6 mm, positive cytology, or symptoms attributable
to the tumor. Nagai et al. [6] evaluated the usefulness of
these guidelines in branch duct IPMN and reported a
high sensitivity (97.3%) but low specificity (29.8%) for
predicting malignancy in branch duct IPMN according
to these guidelines. Furthermore, as patients presented
with more factors, there was an increase in the specificityFigure 4 Macroscopic and pathological findings. The excised pancreas
dimensions of 75 × 45 × 33 mm in the pancreas head. The mural nodule w
it was composed of papillary structures consisting of mucin-containing coland positive predictive value but a decrease in sensitivity
and negative value of the guidelines for making a pre-
operative diagnosis of malignancy. Although preoperative
imaging, such as EUS and MRCP, showed that the case
presented here had four of the factors described in the
previous guidelines, histology indicated that the tumor
was an IPMA.
Some meta-analyses have evaluated the risk of malig-
nancy. For both main duct and branch duct IPMNs, a cyst
size >3 cm, presence of a mural nodule, MPD dilation,
and main duct IPMNs were associated with an increased
risk of malignancy [7]. For branch duct IPMNs, presence
of a mural nodule, MPD dilation, thick septum/wall, and a
cyst size >3 cm were indicators of malignancy [8].
Several recent studies reported that the size of mural
nodules was a more significant malignant factor than
tumor size for predicting the malignancy of branch ductshowed multiple cysts located in the branch pancreatic duct with total
as 25 × 20 × 18 mm in size (A). Pathological examination revealed that
umnar epithelial cells with low-grade atypia (B-D).
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nodule size were 5 to 10 mm [9-12]. In addition, the
MPD size, high serum CEA and carbohydrate antigen
19–9 levels, and high CEA levels in the pancreatic juice
have been reported to be predictive factors for malig-
nancy of branch duct IPMNs [11,13,14]. However, it is
still impossible to detect all malignant cases, even after
examination for these factors and the use of recent im-
aging modalities. EUS is very useful for identifying small
lesions in the pancreas and a helpful modality for the
diagnostic evaluation of branch duct IPMNs [12,15].
Furthermore, the mural nodule size of branch duct
IPMNs detected using EUS was a reliable predictive fac-
tor for malignancy [12]. Magnetic resonance imaging is
also well suited for the detection of pancreatic lesions,
including IPMNs [16]. There have also been meta-
analyses on these tools for differentiating malignant and
benign IPMNs. Cytology based on endoscopic retrograde
cholangiopancreatography was reported to have a high
specificity (97.2%) but a poor sensitivity (35.1%) for dis-
tinguishing benign IPMNs from malignant IPMNs [17].
The level of cyst fluid CEA was mostly ineffective in dif-
ferentiating malignancy; sensitivity was 65%, while speci-
ficity was 66% [18]. In histology, expression of human
telomerase reverse transcriptase was strongly associated
with malignant transformation in IPMNs [19].
In the present case, we diagnosed branch duct IPMN
as a malignant tumor using several findings suggesting a
high possibility of malignancy. We reviewed recent stud-
ies and summarized the mural nodule size of benign
IPMNs in Table 1. To the best of our knowledge, our
case is the largest reported mural nodule in branch duct
IPMA. Here, the operation was justified due to a high
risk of malignancy.Conclusions
Preoperative prediction of malignancy for branch duct
IPMNs is still difficult. Therefore, further studies,
including advances in high-resolution imaging or im-
proved molecular-biological techniques, would be re-
quired for correct and differential diagnosis of IPMA
and IPMC.Table 1 Reported size of mural nodules in branch duct
IPMC and IPMA
Author Year Malignant (mm) Benign (mm)
Kanno et al. [10] 2010 25.8 ± 4.1a 3.9 ± 3.5a
Kobayashi et al. [12] 2012 16.4 (10 to 35)b 4.3 (0 to 15)b
Zhang et al. [13] 2011 13 (3 to 32)b 5 (2 to 7)b
Kawada et al. [20] 2014 15 ± 8a 6 ± 5a
aMeans ± SD. bMedian (range).Consent
Written informed consent was obtained from the pa-
tients for publication of this case report and any accom-
panying images.
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